nd1.1
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2011 (NCT01335347)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Newcastle disease virusImmunity, active
Newcastle disease virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nd1.1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01698060 | Phase 1 | Sep 1, 2012 | Vaxart |
| NCT01335347 | Phase 1 | Apr 1, 2011 | Accelovance, Vaxart |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vaxart | For profit | 2 | 2 | 1 | 2011 |
| Accelovance | For profit | 1 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1